March 24, 2020 –
The Red Book Average Wholesale Price (AWP) for Meloxicam 7.5mg and 15mg is currently listed at $0.05 per pill. This is a significant decrease from the prior listing price of $4.25 per pill. If you have a WCMSAs that have not been submitted for CMS review or a NuShield MSA and the claim has not yet settled, this would be an opportunity to reduce current MSA amounts.
For additional assistance, please contact your dedicated NuQuest Account Executive or the Settlement Consultant Team at:
In addition, the FDA has now approved Voltaren gel, 1% (Diclofenac Sodium 1%) for over-the-counter use. Voltaren gel will be released OTC as Voltaren Arthritis Pain and will be the same strength and formula as the prescription equivalent. Voltaren gel is a non-steroidal anti-inflammatory (NSAID) medication for the treatment of pain associated with osteoarthritis in joints amenable to topical treatment such as the knees and hands. Because OTC drugs are non-Medicare covered, once released on the market and updated in Red Book, this medication will no longer need to be included in MSAs where it is a Medicare covered expense.
NuQuest will continue to monitor these developments and provide updates as they become available.